The Cancer Genome Atlas Network in 2012 reported Wnt/β-catenin pathway mutations in up to 93% of colorectal cancers, and that was prior to the identification of RPSO2/3 translocations and RNF43/ZNRF3 mutations in the Wnt pathway [151]. This evidence concerns the gene ZNRF3 and cancer.